GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dis-Chem Pharmacies Ltd (JSE:DCP) » Definitions » EV-to-EBIT

Dis-Chem Pharmacies (JSE:DCP) EV-to-EBIT : 19.59 (As of May. 22, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Dis-Chem Pharmacies EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Dis-Chem Pharmacies's Enterprise Value is R33,005 Mil. Dis-Chem Pharmacies's EBIT for the trailing twelve months (TTM) ended in Aug. 2023 was R1,685 Mil. Therefore, Dis-Chem Pharmacies's EV-to-EBIT for today is 19.59.

The historical rank and industry rank for Dis-Chem Pharmacies's EV-to-EBIT or its related term are showing as below:

JSE:DCP' s EV-to-EBIT Range Over the Past 10 Years
Min: 13.47   Med: 19.58   Max: 37.69
Current: 19.59

During the past 10 years, the highest EV-to-EBIT of Dis-Chem Pharmacies was 37.69. The lowest was 13.47. And the median was 19.58.

JSE:DCP's EV-to-EBIT is ranked worse than
53.29% of 426 companies
in the Healthcare Providers & Services industry
Industry Median: 18.045 vs JSE:DCP: 19.59

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Dis-Chem Pharmacies's Enterprise Value for the quarter that ended in Aug. 2023 was R24,745 Mil. Dis-Chem Pharmacies's EBIT for the trailing twelve months (TTM) ended in Aug. 2023 was R1,685 Mil. Dis-Chem Pharmacies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Aug. 2023 was 6.81%.


Dis-Chem Pharmacies EV-to-EBIT Historical Data

The historical data trend for Dis-Chem Pharmacies's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dis-Chem Pharmacies EV-to-EBIT Chart

Dis-Chem Pharmacies Annual Data
Trend Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.63 17.23 18.08 21.66 15.65

Dis-Chem Pharmacies Semi-Annual Data
Feb14 Feb15 Aug15 Feb16 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 21.66 - 15.65 -

Competitive Comparison of Dis-Chem Pharmacies's EV-to-EBIT

For the Pharmaceutical Retailers subindustry, Dis-Chem Pharmacies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dis-Chem Pharmacies's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dis-Chem Pharmacies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Dis-Chem Pharmacies's EV-to-EBIT falls into.



Dis-Chem Pharmacies EV-to-EBIT Calculation

Dis-Chem Pharmacies's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=33004.853/1684.985
=19.59

Dis-Chem Pharmacies's current Enterprise Value is R33,005 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Dis-Chem Pharmacies's EBIT for the trailing twelve months (TTM) ended in Aug. 2023 was R1,685 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dis-Chem Pharmacies  (JSE:DCP) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Dis-Chem Pharmacies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Aug. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Aug. 2023 ) =EBIT / Enterprise Value (Q: Aug. 2023 )
=1684.985/24744.7791
=6.81 %

Dis-Chem Pharmacies's Enterprise Value for the quarter that ended in Aug. 2023 was R24,745 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Dis-Chem Pharmacies's EBIT for the trailing twelve months (TTM) ended in Aug. 2023 was R1,685 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dis-Chem Pharmacies EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Dis-Chem Pharmacies's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Dis-Chem Pharmacies (JSE:DCP) Business Description

Traded in Other Exchanges
N/A
Address
23 Stag Road, Glen Austin, Midrand, Johannesburg, GT, ZAF, 1685
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceutical and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries its business operations principally in South Africa.

Dis-Chem Pharmacies (JSE:DCP) Headlines